Evaluation of the effect of IL-22 on human cord blood CD4+ T cells

Javad Arasteh1, Zahra Pourpak, Masoumeh Ebtekar

  • 1Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Interleukin-22 (IL-22) does not influence the expression of CD25 or Foxp3 in cord blood T cells. This study found IL-22 does not affect T cell proliferation or suppression, suggesting a lack of IL-22 receptor 1 on these cells.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Interleukin-22 (IL-22) is a cytokine in the IL-10 family, implicated in inflammatory responses.
  • IL-22 shares similarities with IL-10, including conserved sequences and receptor components (IL-22R1 and IL-10R2).

Purpose of the Study:

  • To investigate the biological activity of IL-22 on human cord blood CD4+CD25- T cells.
  • To determine IL-22's effect on T cell activation, proliferation, and regulatory function.

Main Methods:

  • Cord blood CD4+CD25- T cells were cultured with anti-CD3/CD28 beads, IL-2, and IL-22 for two weeks.
  • Flow cytometry was used to analyze CD25 and Foxp3 expression.
  • T cell proliferation was assessed, and suppression assays were performed.

Main Results:

  • IL-22 did not significantly alter CD25 or Foxp3 expression in cultured T cells.
  • IL-22 was found to have no impact on CD4+ T cell proliferation.
  • No suppressive effect of IL-22 was observed in the conducted assays.

Conclusions:

  • Umbilical cord blood T cells likely do not express the IL-22 receptor 1 (IL-22R1) on their surface.
  • IL-22 does not appear to play a direct role in the early activation or function of these specific T cells.

Related Concept Videos